Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prokidney (PROK) EBT (2022 - 2025)

Prokidney (PROK) has disclosed EBT for 4 consecutive years, with -$42.4 million as the latest value for Q4 2025.

  • Quarterly EBT rose 9.29% to -$42.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$151.2 million through Dec 2025, up 7.77% year-over-year, with the annual reading at -$151.2 million for FY2025, 7.77% up from the prior year.
  • EBT for Q4 2025 was -$42.4 million at Prokidney, down from -$35.3 million in the prior quarter.
  • The five-year high for EBT was -$18.9 million in Q4 2023, with the low at -$66.5 million in Q1 2022.
  • Average EBT over 4 years is -$37.0 million, with a median of -$35.8 million recorded in 2023.
  • The sharpest move saw EBT surged 46.47% in 2023, then tumbled 147.09% in 2024.
  • Over 4 years, EBT stood at -$25.8 million in 2022, then grew by 26.72% to -$18.9 million in 2023, then crashed by 147.09% to -$46.8 million in 2024, then increased by 9.29% to -$42.4 million in 2025.
  • According to Business Quant data, EBT over the past three periods came in at -$42.4 million, -$35.3 million, and -$36.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.